TiumBio

A drug developer working on treatments for cancer based in South Korean.

Launch date

2016

Employees

Market cap

Net debt

KRW1.5b

Enterprise valuation

$125m (Public information from Jun 2024)

Seongnam-si Gyeonggi-do (HQ)

http://tiumbio.com

https://www.linkedin.com/company/tiumbio/

Deals in current and previous year:

Authorizing premium user...